Elsevier to Publish The Journal of Economic Asymmetries Beginning in January 2013
OXFORD, England, December 19, 2012 /PRNewswire/ --
Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce that they have entered into an agreement with the Athenian Policy Forum (APF) represented by Professor Anastasios G. Malliaris to publish The Journal of Economic Asymmetries (JEA), the official journal of APF beginning in January 2013.
The journal publishes scholarly articles on economic, financial, technological and legal asymmetries within and among markets in an increasingly globalized world. Editor Professor Anastasios G. Malliaris stated, "On behalf of the Board of Directors and the Fellows of the Athenian Policy Forum, I am delighted to see the Journal of Economic Asymmetries join Elsevier. We expect the wider visibility of the journal, now that it is part of the Elsevier family, will offer a much greater incentive to scholars and policy makers to submit their research papers to the journal. We wish to emphasize that the journal has three globally known co-editors who specialize in economic problems and associated policies across three geographical regions: the Americas, Europe and Asia."
Jenny Henzen, Economics Publisher at Elsevier, said, "We are pleased to be announcing this new publishing agreement with APF and look forward to working with the Editor Professor Anastasios G. Malliaris."
Effective January 1, 2013 Elsevier will publish The Journal of Economic Asymmetries.
For more information go to: http://www.elsevier.com/locate/jeca
About Athenian Policy Forum
The major objective of the Athenian Policy Forum is to promote independent objective analysis and stimulate public discussion on issues and problems relating to economic adjustment. It contributes to this goal by disseminating the results of innovative research on the economic implications of the changing forces of demography, the environment, social and political transformation, technology and trade.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, MD Consult and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
More by this Source
Antonio Ceriello, MD, Appointed Editor-in-Chief, Diabetes Research and Clinical Practice
30 Jun, 2016, 10:21 BST
Elsevier to Develop First-ever Benchmark Report on US Cancer Research Landscape
29 Jun, 2016, 09:59 BST
Get content for your website
Enhance your website's or blog's content with PR Newswire's customised real-time news feeds.
Contact PR Newswire
Send us an email at MarketingUK@prnewswire.co.uk or call us at +44 (0)20 7454 5382
Become a PR Newswire client
Request more information about PR Newswire products & services or call us at +44 (0)20 7454 5382